this news from 3 weeks ago is in reality a significant positive one and looks like many people still didnt realize this .oh dear cant wait for the phase 2 data this one could be a pure goldmine .....
No Serious Adverse Events (SAE’s) have been reported to date. The Data Safety Monitoring Board have been periodically evaluating the safety related trial data and have on each occasion recommended continuation of the trial with no safety concerns
ANP Price at posting:
6.0¢ Sentiment: Buy Disclosure: Held
